Coexistence of restless legs syndrome and multiple sclerosis aggravates anxiety and depression.


Journal

Arquivos de neuro-psiquiatria
ISSN: 1678-4227
Titre abrégé: Arq Neuropsiquiatr
Pays: Germany
ID NLM: 0125444

Informations de publication

Date de publication:
02 2022
Historique:
received: 11 10 2020
accepted: 11 03 2021
pubmed: 24 2 2022
medline: 13 4 2022
entrez: 23 2 2022
Statut: ppublish

Résumé

Among the comorbidities that accompany multiple sclerosis (MS), restless legs syndrome (RLS) is one of the most common. Anxiety and depression are common psychological comorbidities that impact the quality of life of patients with MS (PwMS), as well as patients with RLS. To investigate the psychiatric burden of MS and RLS coexistence, we conducted a nationwide, multicenter and cross-sectional survey. Participants were assessed by using demographic and clinical parameters along with the Hamilton Anxiety and Hamilton Depression Scales (HAM-A and HAM-D). Out of the 1,068 participants, 173 (16.2%) were found to have RLS [RLS(+)] and 895 (83.8%) did not [RLS(-)]. The mean scores for HAM-A and HAM-D were significantly higher among RLS(+) subjects than among RLS(-) subjects (p<0.001 for all variables). According to our data, the presence of RLS in PwMS may increase the occurrence of both anxiety and depression symptoms. Awareness and treatment of RLS in PwMS could possibly reduce the symptoms of psychiatric comorbidities originating from RLS.

Sections du résumé

BACKGROUND
Among the comorbidities that accompany multiple sclerosis (MS), restless legs syndrome (RLS) is one of the most common. Anxiety and depression are common psychological comorbidities that impact the quality of life of patients with MS (PwMS), as well as patients with RLS.
OBJECTIVE
To investigate the psychiatric burden of MS and RLS coexistence, we conducted a nationwide, multicenter and cross-sectional survey.
METHODS
Participants were assessed by using demographic and clinical parameters along with the Hamilton Anxiety and Hamilton Depression Scales (HAM-A and HAM-D).
RESULTS
Out of the 1,068 participants, 173 (16.2%) were found to have RLS [RLS(+)] and 895 (83.8%) did not [RLS(-)]. The mean scores for HAM-A and HAM-D were significantly higher among RLS(+) subjects than among RLS(-) subjects (p<0.001 for all variables).
CONCLUSIONS
According to our data, the presence of RLS in PwMS may increase the occurrence of both anxiety and depression symptoms. Awareness and treatment of RLS in PwMS could possibly reduce the symptoms of psychiatric comorbidities originating from RLS.

Identifiants

pubmed: 35195221
pii: S0004-282X2022005003202
doi: 10.1590/0004-282X-ANP-2020-0400
pmc: PMC9648925
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

168-172

Références

J Sleep Res. 2020 Jun;29(3):e12880
pubmed: 31157499
Lancet Neurol. 2010 Aug;9(8):820-8
pubmed: 20650403
Sleep. 2008 Jul;31(7):944-52
pubmed: 18655317
Mult Scler Relat Disord. 2019 Sep;34:83-90
pubmed: 31233959
Neurol Res. 2018 Jul;40(7):586-592
pubmed: 29577828
Mult Scler Relat Disord. 2017 Feb;12:54-58
pubmed: 28283108
J Neurol Neurosurg Psychiatry. 2017 Aug;88(8):697-708
pubmed: 28285265
Sleep Breath. 2015 Dec;19(4):1355-60
pubmed: 26003788
Arq Neuropsiquiatr. 2018 May;76(5):296-301
pubmed: 29898075
Sleep Med. 2014 Aug;15(8):860-73
pubmed: 25023924
Ann Neurol. 2011 Feb;69(2):292-302
pubmed: 21387374
Mult Scler Relat Disord. 2020 Jul;42:102055
pubmed: 32473575
JAMA Netw Open. 2019 Aug 2;2(8):e199966
pubmed: 31441941
Curr Neurol Neurosci Rep. 2019 Aug 28;19(10):77
pubmed: 31463644
J Neurol Neurosurg Psychiatry. 2004 Feb;75(2):226-30
pubmed: 14742594

Auteurs

Serhan Sevim (S)

Mersin University, School of Medicine, Department of Neurology, Mersin, Turkey.

Meltem Demirkiran (M)

Çukurova University, Department of Neurology, Adana, Turkey.

Murat Terzi (M)

Ondokuz Mayıs University, Department of Neurology, Samsun, Turkey.

Nur Yüceyar (N)

Ege University, Department of Neurology, İzmir, Turkey.

Bahar Taşdelen (B)

Mersin University, Department of Biostatistics, Mersin, Turkey.

Egemen Idiman (E)

Dokuz Eylül University, Department of Neurology, İzmir, Turkey.

Murat Kürtüncü (M)

İstanbul University, Department of Neurology, İstanbul, Turkey.

Cavit Boz (C)

Karadeniz Technical University, Department of Neurology, Trabzon, Turkey.

Deniz Tuncel (D)

Sütçü İmam University, Department of Neurology, Kahramanmaraş, Turkey.

Rana Karabudak (R)

Hacettepe University, Department of Neurology, Ankara, Turkey.

Aksel Siva (A)

İstanbul University, Cerrahpaşa School of Medicine, Department of Neurology, İstanbul, Turkey.

Abdülcemal Özcan (A)

İnönü University, Department of Neurology, Malatya, Turkey.

Münife Neyal (M)

Sanko University, Department of Neurology, Gaziantep, Turkey.

Başak Karakurum Göksel (BK)

Başkent University, Department of Neurology, Adana, Turkey.

Gülcan Baran Gazaloğlu (GB)

Mersin University, Department of Neurology, Mersin, Turkey.

Mehmet Balal (M)

Çukurova University, Department of Neurology, Adana, Turkey.

Sedat Şen (S)

Ondokuz Mayıs University, Department of Neurology, Samsun, Turkey.

Meltem Alkaya Baklan (MA)

Ege University, Department of Neurology, İzmir, Turkey.

Tuncay Gündüz (T)

İstanbul University, Department of Neurology, İstanbul, Turkey.

Aslı Tuncer (A)

Hacettepe University, Department of Neurology, Ankara, Turkey.

Uğur Uygunoğlu (U)

İstanbul University, Cerrahpaşa School of Medicine, Department of Neurology, İstanbul, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH